Form 4: Charles River Labs Director Trades Common Stock

Director James C. Foster reported transactions involving Charles River Laboratories International, Inc. common stock.

Summary

• Director James C. Foster reported the acquisition of 1,596 shares of common stock on May 30, 2026, at a price of $180.71 per share.
• Following this transaction, Foster beneficially owns 279,957 shares of common stock directly.
• The filing also lists indirect beneficial ownership of additional shares through various trusts and a GRAT, totaling 19,203 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions without providing new financial or strategic information.

Positives

• Director James C. Foster acquired additional shares of common stock, indicating continued investment in the company.
• The direct beneficial ownership of 279,957 shares demonstrates a significant personal stake in Charles River Laboratories.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal strategic shifts. They provide transparency into the holdings and trading activities of company insiders.

Stakeholder Impact

• Shareholders gain transparency into director's stock transactions and holdings.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Beneficial Ownership, Charles River Laboratories, Director Transaction, Common Stock